Skip to main content Skip to footer site map
  • DONATE

PBS NewsHour | Clip | AstraZeneca scrambles to address concerns about vaccine data

AstraZeneca is facing new questions today after a highly unusual reprimand from a board overseeing the company’s clinical vaccine trials.The company is scrambling to respond to allegations that it used misleading data when claiming its vaccine was 79 percent effective against COVID-19 symptoms. Nick Schifrin breaks down the latest with epidemiologist Dr. Jennifer Nuzzo of Johns Hopkins University.

0:06:26 | AIRED: 3/23/2021 |
THIRTEEN Passport | A benefit of membership | Activate Now
Membership Promo

NEWSLETTER SIGNUP

CONNECT WITH THIRTEEN